Anti-Androgens May Protect Against Severe COVID-19 Outcomes: Results From a Prospective Cohort Study of 77 Hospitalized Men

    January 2021 in “ Journal of The European Academy of Dermatology and Venereology ”
    Andy Goren, Carlos Gustavo Wambier, Sabina Herrera, John D. McCoy, Sergio Vano-Galvan, Francesca Gioia, Belén Comeche, Raquel Ron, Sergio Serrano-Villar, Paulo Müller Ramos, Flavio A. Cadegiani, Maja Kovacevic, Antonella Tosti, Jerry Shapiro, Rodney Sinclair
    Image of study
    TLDR Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.
    A prospective cohort study involving 77 hospitalized men found that the use of anti-androgens could potentially reduce the severity of COVID-19 outcomes. The study divided the participants into two groups: those who had been on anti-androgens for at least 6 months before hospitalization and those who hadn't. The results indicated a significantly lower rate of ICU admission in the group taking anti-androgens (8%) compared to the group not taking them (58%), even after adjusting for age. Anti-androgens like finasteride, dutasteride, and spironolactone could potentially improve outcomes for men infected with SARS-CoV-2. However, due to the small study size, the authors recommend larger studies for further investigation.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community A little over two years on Dut

      in Finasteride/Dutasteride  59 upvotes 1 month ago
      A 23-year-old male has been using Dutasteride for over two years to address hair thinning, with some success in temple regrowth but continued thinning on top. He is considering adding Minoxidil to his routine and is contemplating lifestyle changes like quitting smoking and drinking to improve hair density.

      community Monthly Reminder.

       8 upvotes 6 years ago
      Various treatments for male pattern baldness including Minoxidil, Finasteride/Dutasteride, hair systems, and oral anti-androgens such as Spironolactone and Flutamide. It also mentions dermarolling as a possible treatment in conjunction with minoxidil.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

    Related Research

    1 / 1 results